Early cross-coronavirus reactive signatures of humoral immunity against COVID-19

The introduction of vaccines has inspired hope in the battle against SARS-CoV-2. However, the emergence of viral variants, in the absence of potent antivirals, has left the world struggling with the uncertain nature of this disease. Antibodies currently represent the strongest correlate of immunity...

Descripción completa

Detalles Bibliográficos
Autores principales: Kaplonek, Paulina, Wang, Chuangqi, Bartsch, Yannic, Fischinger, Stephanie, Gorman, Matthew J., Bowman, Kathryn, Kang, Jaewon, Dayal, Diana, Martin, Patrick, Nowak, Radoslaw P., Villani, Alexandra-Chloé, Hsieh, Ching-Lin, Charland, Nicole C., Gonye, Anna L.K., Gushterova, Irena, Khanna, Hargun K., LaSalle, Thomas J., Lavin-Parsons, Kendall M., Lilley, Brendan M., Lodenstein, Carl L., Manakongtreecheep, Kasidet, Margolin, Justin D., McKaig, Brenna N., Rojas-Lopez, Maricarmen, Russo, Brian C., Sharma, Nihaarika, Tantivit, Jessica, Thomas, Molly F., Sade-Feldman, Moshe, Feldman, Jared, Julg, Boris, Nilles, Eric J., Musk, Elon R., Menon, Anil S., Fischer, Eric S., McLellan, Jason S., Schmidt, Aaron, Goldberg, Marcia B., Filbin, Michael R., Hacohen, Nir, Lauffenburger, Douglas A., Alter, Galit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8943686/
https://www.ncbi.nlm.nih.gov/pubmed/34652962
http://dx.doi.org/10.1126/sciimmunol.abj2901

Ejemplares similares

Ejemplares similares